Literature DB >> 21926949

The role of three-dimensional ultrasound in the diagnosis of fetal congenital anomalies: a review.

G Rizzo1, M Pietrolucci, E Aiello, S Mammarella, C Bosi, D Arduini.   

Abstract

The objective of this review was to establish whether three-dimensional (3D) and four dimensional (4D) ultrasonography adds diagnostic information to what is currently provided by two-dimensional (2D) ultrasound in the diagnosis of the most frequent fetal structural defects: congenital heart disease and central nervous system congenital anomalies. There are evidences suggesting that 3D ultrasound allows to reduce the operator dependency in the visualization of standard diagnostic planes, thus reducing the examination time require for the obstetric ultrasound examination, with minimal impact on the visualization quality of the anatomic landmarks. Furthermore, operators with minimal experience may record cardiac or brain volumes that can be successfully analyzed off-line locally or sent by internet to experts for remote review. As a consequence 3D ultrasonography promises to become the method of choice for diagnosis congenital structural defects.

Entities:  

Mesh:

Year:  2011        PMID: 21926949

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  3 in total

1.  Management of Congenital Diaphragmatic Hernia in Newborn - Paradigm Shift and Ethical Issues.

Authors:  Sushmita Nitin Bhatnagar; Yogesh Kumar Sarin
Journal:  Indian J Pediatr       Date:  2017-06-16       Impact factor: 1.967

2.  A comparison of standard two-dimensional ultrasound to three-dimensional volume sonography for routine second-trimester fetal imaging.

Authors:  M E Roy-Lacroix; F Moretti; Z M Ferraro; L Brosseau; J Clancy; K Fung-Kee-Fung
Journal:  J Perinatol       Date:  2017-01-26       Impact factor: 2.521

3.  Fetal cholelithiasis: a diagnostic update and a literature review.

Authors:  Stefania Triunfo; Paolo Rosati; Pietro Ferrara; Antonio Gatto; Giovanni Scambia
Journal:  Clin Med Insights Case Rep       Date:  2013-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.